BUSINESS RISK, DIVIDEND POLICY, CAPITAL STRUCTURE ON FINANCIAL PERFORMANCE: A STUDY IN INDONESIAN PHARMACEUTICAL COMPANIES. IJEIRC. 2024;1(10):41-63. doi:10.61796/ijeirc.v1i10.275